Comparison of the Antiviral Activities of Various Cloned Human Interferon-α Subtypes in Mammalian Cell Cultures

References

1. Baglioni C. 1979; Interferon-induced enzymatic activities and their role in the antiviral state. Cell 17:255–264
   [Google Scholar]
2. Bridgen P. J., Anfinsen C. B., Corley L., Bose S., Zoon K. C., Ruegg U. T. 1977; Human lymphoblastoid interferon: large scale production and partial purification. Journal of Biological Chemistry 252:6585–6587
   [Google Scholar]
3. Campbell J. B., Grunberger T., Kochman M. A., White S. L. 1975; A microplaque reduction assay for human and mouse interferon. Canadian Journal of Microbiology 21:1247–1253
   [Google Scholar]
4. Czarniecki C. W., Sreevalsan T., Friedman R. M., Panet A. 1981; Dissociation of interferon effects on murine leukemia virus and encephalomyocarditis virus replication in mouse cells. Journal of Virology 37:827–831
   [Google Scholar]
5. Desmyter J., Stewart W. E. 1976; Molecular modification of interferon: attainment of human interferon in a conformation active on cat cells but inactive on human cells. Virology 70:451–458
   [Google Scholar]
6. Desmyter J., Rawls W. C., Melnick J. L. 1970; Sensitivity of rabbit cells to primate interferons. Annals of the New York Academy of Sciences 173:492–504
   [Google Scholar]
7. Gidlund M., Orn A., Wigzell H., Senik A., Gresser I. 1978; Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature, London 273:759–761
   [Google Scholar]
8. Goeddel D. V., Yelverton E., Ullrich A., Heyneker H. L., Miozzari G., Holmes W., Seeburg P. H., Dull T., May L., Stebbing N., Crea R., Maeda S., McCandliss R., Sloma A., Tabor J. M., Gross M., Familletti P. C., Pestka S. 1980; Human leukocyte interferon produced by E. coli is biologically active. Nature, London 287:411–416
   [Google Scholar]
9. Goeddel D. V., Leung D. W., Dull T. J., Gross M., Lawn R. M., McCandliss R., Seeburg P. H., Ullrich A., Yelverton E., Gray P. W. 1981; The structure of eight distinct cloned human leukocyte interferon cDNAs. Nature, London 290:20–26
   [Google Scholar]
10. Gresser I., Bandu M. T., Brouty-Boye D., Tovey M. 1974; Pronounced antiviral activity of human interferon on bovine and porcine cells. Nature, London 251:543–545
    [Google Scholar]
11. Herberman R. B., Djeu J. V., Ortaldo J. R., Holden H. T., West W. H., Bonnard G. D. 1978; Role of interferon in augmentation of natural and antibody dependent cell-mediated-cytotoxicity. Cancer Treatment Reports 62:1893–1896
    [Google Scholar]
12. Lazar R., Breining M. K., Armstrong J. A., Ho M. 1980; Response of cloned progeny of clinical isolates of herpes simplex virus to human leukocyte interferon. Infection and Immunity 28:708–712
    [Google Scholar]
13. McGill J. I., Collins P., Cantell K., Jones B. R., Finter N. B. 1976; Optimal schedules for use of interferon in the corneas of rabbits with herpes simplex keratitis. Journal of Infectious Diseases 133:13–19
    [Google Scholar]
14. Nagata S., Taira H., Hall A., Johnsrud L., Streuli M., Ecsodi J., Boll W., Cantell K., Weissmann C. 1980a; Synthesis in E. coli of a polypeptide with human leukocyte interferon activity. Nature, London 284:316–320
    [Google Scholar]
15. Nagata S., Mantei N., Weissmann C. 1980b; The structure of one of the eight or more distinct chromosomal genes for human interferon-α. Nature, London 287:401–408
    [Google Scholar]
16. Otto M. J., Sedmak J. J., Grossberg S. E. 1980; Enzymatic modifications of human fibroblast and leukocyte interferons. Journal of Virology 35:390–399
    [Google Scholar]
17. Rubinstein M., Levy W. P., Moschera J. A., Lai C. Y., Hershberg R. D., Bartlett R. T., Pestka S. 1981; Human leukocyte interferon: isolation and characterization of several molecular forms. Archives of Biochemistry and Biophysics (in press)
    [Google Scholar]
18. Schellekens H., Weimar W., Cantell K., Stitz L. 1979; Antiviral effect of interferon in vivo may be mediated by the host. Nature, London 278:742
    [Google Scholar]
19. Smolin G., Stebbing N., Friedlaender M., Friedlaender R., Okumoto M. 1981; Antiviral effects of natural and cloned human leukocyte interferons in herpes virus infections of the rabbit eye. Archives of Ophthalmology (in press)
    [Google Scholar]
20. Stebbing N., Dawson K. M., Lindley I. J. D. 1978; Requirement for macrophages for interferon to be effective against encephalomyocarditis virus infection of mice. Infection and Immunity 19:5–11
    [Google Scholar]
21. Stebbing N., Weck P. K., Fenno J. T., Apperson S., Lee S. H. 1981; Comparison of the biological properties of natural and recombinant DNA derived human interferons. The Biology of the Interferon System Amsterdam: Elsevier/North-Holland; (in press)
    [Google Scholar]
22. Stewart W. E. H. 1979 The Interferon System New York: Springer-Verlag;
    [Google Scholar]
23. Stewart W. E., Desmyter J. 1975; Molecular heterogeneity of human leukocyte interferon: two populations differing in molecular weights, requirements for renaturation, and cross-species antiviral activity. Virology 67:68–73
    [Google Scholar]
24. Stewart W. E., Havell E. A. 1980; Characterization of a subspecies of mouse interferon cross-reactive on human cells and antigenically related to human leukocyte interferon. Virology 101:315–318
    [Google Scholar]
25. Streuli M., Hall A., Boll W., Stewart W. E., Nagata S., Weissmann C. 1981; Target Cell Specificity of two species of human interferon-α produced in Escherichia coli and of hybrid molecules derived from them. Proceedings of the National Academy of Sciences of the United States of America 78:2848–2852
    [Google Scholar]
26. Yelverton E., Leung D., Weck P., Gray P. W., Goeddel D. V. 1981; Bacterial synthesis of a novel human leukocyte interferon. Nucleic Acids Research 9:731–741
    [Google Scholar]